Paper30441908
sdAb-DB: The Single Domain Antibody Database.
Wilton EE and 4 others. ACS Synth Biol, 2018. Cited by 64 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. sdAb-DB: The Single Domain Antibody Database. Papers, record 30441908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30441908
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Databases, Protein | Major topic |
| Single-Domain Antibodies | Major topic |
| Bioengineering | |
| Synthetic Biology | |
| User-Computer Interface |
Source PubMed
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,939,733 | Artificial Intelligence-Driven Nanobody Engineering for Pathogen Recognition: From Functional Epitope Prioritization to Multimodal Foundation Models. | Biomolecules | 2026 | https://conductscience.org/library/papers/42939733 | PubMed |
| 42,824,780 | Beyond affinity: AI-supported developability assessment and multi-objective optimization in antibody development. | Antib Ther | 2026 | https://conductscience.org/library/papers/42824780 | PubMed |
| 42,344,233 | NanoBind: Mechanism-Driven Deep Learning of Nanobody-Antigen Molecular Recognition. | Research (Wash D C) | 2026 | https://conductscience.org/library/papers/42344233 | PubMed |
| 41,808,445 | Predicting antibody-antigen affinity with a dual-level representation model. | Bioinformatics | 2026 | https://conductscience.org/library/papers/41808445 | PubMed |
| 41,723,205 | A Unified Dataset for Antibody and Nanobody Design Including Sequence, Structure, and Binding Affinity Data. | Sci Data | 2026 | https://conductscience.org/library/papers/41723205 | PubMed |
| 41,660,941 | RASP: rapid antibody functional screening by pentavalent phage display. | MAbs | 2026 | https://conductscience.org/library/papers/41660941 | PubMed |
| 41,440,489 | Species-Dependent Structural Variations in Single-Domain Antibodies. | Antibodies (Basel) | 2025 | https://conductscience.org/library/papers/41440489 | PubMed |
| 40,533,487 | A three dimensional immunolabeling method with peroxidase-fused nanobodies and fluorochromized tyramide-glucose oxidase signal amplification. | Commun Biol | 2025 | https://conductscience.org/library/papers/40533487 | PubMed |
| 40,427,503 | Small but Mighty: Nanobodies in the Fight Against Infectious Diseases. | Biomolecules | 2025 | https://conductscience.org/library/papers/40427503 | PubMed |
| 39,915,791 | Unveiling the new chapter in nanobody engineering: advances in traditional construction and AI-driven optimization. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/39915791 | PubMed |
| 39,688,476 | NABP-BERT: NANOBODY®-antigen binding prediction based on bidirectional encoder representations from transformers (BERT) architecture. | Brief Bioinform | 2024 | https://conductscience.org/library/papers/39688476 | PubMed |
| 39,027,650 | A comprehensive overview of recent advances in generative models for antibodies. | Comput Struct Biotechnol J | 2024 | https://conductscience.org/library/papers/39027650 | PubMed |
| 38,960,409 | Antibody design using deep learning: from sequence and structure design to affinity maturation. | Brief Bioinform | 2024 | https://conductscience.org/library/papers/38960409 | PubMed |
| 38,898,362 | Nanobody engineering: computational modelling and design for biomedical and therapeutic applications. | FEBS Open Bio | 2025 | https://conductscience.org/library/papers/38898362 | PubMed |
| 38,681,780 | Physicochemical differences between camelid single-domain antibodies and mammalian antibodies. | Turk J Biol | 2023 | https://conductscience.org/library/papers/38681780 | PubMed |
| 38,300,518 | NanoLAS: a comprehensive nanobody database with data integration, consolidation and application. | Database (Oxford) | 2024 | https://conductscience.org/library/papers/38300518 | PubMed |
| 38,162,639 | Advances in research based on antibody-cell conjugation. | Front Immunol | 2023 | https://conductscience.org/library/papers/38162639 | PubMed |
| 37,957,563 | DG-Affinity: predicting antigen-antibody affinity with language models from sequences. | BMC Bioinformatics | 2023 | https://conductscience.org/library/papers/37957563 | PubMed |
| 37,781,019 | Characterization of Foot-and-Mouth Disease Virus Serotype O-Specific Single Domain Antibody Expressed in the pET Expression System. | Indian J Microbiol | 2023 | https://conductscience.org/library/papers/37781019 | PubMed |
| 37,418,494 | Bypassing the Need for Cell Permeabilization: Nanobody CDR3 Peptide Improves Binding on Living Bacteria. | Bioconjug Chem | 2023 | https://conductscience.org/library/papers/37418494 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30441908
GET https://conductscience.org/api/papers/v1/30441908/cited_by?page=2